546
Participants
Start Date
March 31, 2003
Primary Completion Date
May 31, 2004
Study Completion Date
May 31, 2004
Radafaxine
GSK Investigational Site, Farmington
GSK Investigational Site, Lawrence
GSK Investigational Site, Conshohocken
GSK Investigational Site, Glen Burnie
GSK Investigational Site, Charlotte
GSK Investigational Site, Maitland
GSK Investigational Site, Miami
GSK Investigational Site, North Miami
GSK Investigational Site, Largo
GSK Investigational Site, Cleveland
GSK Investigational Site, Dayton
GSK Investigational Site, Farmington Hills
GSK Investigational Site, Brown Deer
GSK Investigational Site, Minneapolis
GSK Investigational Site, Edwardsville
GSK Investigational Site, Little Rock
GSK Investigational Site, Oklahoma City
GSK Investigational Site, Irving
GSK Investigational Site, Dallas
GSK Investigational Site, Houston
GSK Investigational Site, Portland
GSK Investigational Site, Portland
GSK Investigational Site, Eugene
GSK Investigational Site, Seattle
GSK Investigational Site, Tacoma
GSK Investigational Site, Newport Beach
GSK Investigational Site, Clementon
GSK Investigational Site, Kenilworth
GSK Investigational Site, Woodstock
Lead Sponsor
GlaxoSmithKline
INDUSTRY